12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
In Tuesday's pre-market session, several healthcare stocks experienced significant movements. Ensysce Biosciences and Genprex saw substantial gains, while GRI Bio and Sensei Biotherapeutics faced notable declines. Medpace Holdings also saw a decrease following its Q3 earnings report.
October 22, 2024 | 12:07 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
GRI Bio's stock fell by 24.7% in pre-market trading, indicating negative sentiment or news.
The significant decline suggests negative news or sentiment impacting the stock, likely leading to short-term losses.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Medpace Holdings' stock fell by 11.32% following its Q3 earnings report, suggesting a negative market reaction.
The decline following the earnings report suggests that the results were below market expectations, leading to short-term negative impact.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Sensei Biotherapeutics' stock decreased by 21.03% in pre-market trading, reflecting negative market sentiment.
The sharp decline indicates negative sentiment or news, likely resulting in short-term downward pressure on the stock.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Ensysce Biosciences' stock surged by 134.8% in pre-market trading, indicating strong investor interest.
The significant price increase suggests positive sentiment or news driving investor interest, likely leading to short-term gains.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Genprex's stock rose by 118.54% in pre-market trading, reflecting a strong positive market reaction.
The large increase in stock price indicates a strong positive catalyst, likely leading to continued short-term upward momentum.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100